Utilizing pH-sensitive nanoparticles in cancer radiotherapy: mechanisms and therapeutic potential

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.2166010.3322/caac.21660 ↗

2. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229–263. https://doi.org/10.3322/caac.2183410.3322/caac.21834 ↗

3. Wang Y, Xu Y, Song J, Liu X, Liu S, Yang N, Wang L, Liu Y, Zhao Y, Zhou W, Zhang Y (2024) Tumor cell-targeting and tumor microenvironment-responsive nanoplatforms for the multimodal imaging-guided photodynamic/photothermal/chemodynamic treatment of cervical cancer. Int J Nanomedicine 19:5837–5858. https://doi.org/10.2147/IJN.S46604210.2147/IJN.S466042 ↗

4. He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, He H, Tang S, Sun Y, Liu F, Ding X, Zhang Y, Hu S, Xia L (2019) Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng 13:58. https://doi.org/10.1186/s13036-019-0189-910.1186/s13036-019-0189-9 ↗

5. Ning Q, Yang T, Guo X, Huang Y, Gao Y, Liu M, Yang P, Guan Y, Liu N, Wang Y, Chen D (2023) CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. J Viral Hepat 30:951–958. https://doi.org/10.1111/jvh.1388610.1111/jvh.13886 ↗

6. Kolimi P, Narala S, Nyavanandi D, Youssef AAA, Dudhipala N (2022) Innovative treatment strategies to accelerate wound healing: trajectory and recent advancements. Cells 11:2439. https://doi.org/10.3390/cells1115243910.3390/cells11152439 ↗

7. Addissouky TA, El Sayed IET, Ali MM, Alubiady MHS, Wang Y (2024) Recent developments in the diagnosis, treatment, and management of cardiovascular diseases through artificial intelligence and other innovative approaches. J Biomed Res 5:29–4010.46439/biomedres.5.041 ↗

8. Bemidinezhad A, Radmehr S, Moosaei N, Efati Z, Kesharwani P, Sahebkar A (2024) Enhancing radiotherapy for melanoma: the promise of high-Z metal nanoparticles in radiosensitization. Nanomedicine 19:2391–2411. https://doi.org/10.1080/17435889.2024.240332510.1080/17435889.2024.2403325 ↗

9. Chen Y, Li L, Chen X, Yan Q, Hu X (2025) The efficacy of decision aids on enhancing early cancer screening: a meta-analysis of randomized controlled trials. Worldviews Evid Based Nurs 22:e70048. https://doi.org/10.1111/wvn.7004810.1111/wvn.70048 ↗

10. Li J, He HG, Guan C, Ding Y, Hu X (2025) Dynamic joint prediction model of severe radiation-induced oral mucositis among nasopharyngeal carcinoma: a prospective longitudinal study. Radiother Oncol 209:110993. https://doi.org/10.1016/j.radonc.2025.11099310.1016/j.radonc.2025.110993 ↗

11. Fabbrizi MR, Parsons JL (2020) Radiotherapy and the cellular DNA damage response: current and future perspectives on head and neck cancer treatment. Cancer Drug Resist 3:775. https://doi.org/10.20517/cdr.2020.4910.20517/cdr.2020.49 ↗

12. Bemidinezhad A, Mirzavi F, Gholamhosseinian H, Gheybi F, Soukhtanloo M (2022) Green synthesis of glucose-coated gold nanoparticles for improving radiosensitivity in human U87 glioblastoma cell line. Nanomedicine J 9. https://doi.org/10.22038/nmj.2022.67425.1714.10.22038/nmj.2022.67425.1714 ↗

13. Srinivasan D, Subbarayan R, Srivastava N, Radhakrishnan A, Adtani PN, Chauhan A, Krishnamoorthy L (2024) A comprehensive overview of radiation therapy impacts of various cancer treatments and pivotal role in the immune system. Cell Biochem Funct 42:e4103. https://doi.org/10.1002/cbf.410310.1002/cbf.4103 ↗

14. Leung K-N, Leung JK (2024) Cancer radiotherapy with mini neutron/gamma-ray generators. Adv Radiother Nuclear Med 2:3920. https://doi.org/10.36922/arnm.392010.36922/arnm.3920 ↗

15. Bemidinezhad A, Al-Baghdadi A, Alsarray A, Abolhassani Y, Kenjayev Y, Gheybi F (2025) Enhancing radiotherapy for hypoxic tumors: integrative strategies using bacteria and nanoparticles. IET Nanobiotechnol 2025:2687439. https://doi.org/10.1049/nbt2/268743910.1049/nbt2/2687439 ↗

16. Liu B, Zhou H, Tan L, Siu KTH, Guan XY (2024) Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther 9:175. https://doi.org/10.1038/s41392-024-01856-710.1038/s41392-024-01856-7 ↗

17. Bemidinezhad A, Abolhassani Y, Sarabian Tabrizi A, Noroozi-Karimabad M, Parsa-Kondelaji M, Roshani R, Gheybi F (2025) Aptamers in combination therapies for enhanced radiosensitization in cancer. Iran J Biotechnol 23:1–25. https://doi.org/10.30498/ijb.2025.491856.403210.30498/ijb.2025.491856.4032 ↗

18. Bemidinezhad A, Abolhassani Y, Noroozi-Karimabad M, Abroumand Gholami A, Alalikhan A, Roshani R, Parsa-Kondelaji M, Gheybi F (2025) Revolutionizing cancer therapy: monoclonal antibodies in radiosensitization. Bioimpacts 15:30996. https://doi.org/10.34172/bi.3099610.34172/bi.30996 ↗

19. Bemidinezhad A, Abolhassani Y, Feiz K, Parsa-Kondelaji M, Soukhtanloo M (2025) Carbon and phosphorus quantum dots: advancing radiotherapy through innovative radiosensitization. Biochem Biophys Res Commun 773:152054. https://doi.org/10.1016/j.bbrc.2025.15205410.1016/j.bbrc.2025.152054 ↗

20. Chen H, Han Z, Luo Q, Wang Y, Li Q, Zhou L, Zuo H (2022) Radiotherapy modulates tumor cell fate decisions: a review. Radiat Oncol 17:196. https://doi.org/10.1186/s13014-022-02171-710.1186/s13014-022-02171-7 ↗

21. Vaes RDW, Hendriks LEL, Vooijs M, De Ruysscher D (2021) Biomarkers of radiotherapy-induced immunogenic cell death. Cells 10:930. https://doi.org/10.3390/cells1004093010.3390/cells10040930 ↗

22. Heidarian F, Alavizadeh SH, Kalantari MR, Hoseini SJ, Farshchi HK, Jaafari MR, Doagooyan M, Bemidinezhad A, Kesharwani P, Sahebkar A, Gheybi F (2024) Ellagic acid nanoliposomes potentiate therapeutic effects of PEGylated liposomal doxorubicin in melanoma: an in vitro and in vivo study. J Drug Deliv Sci Technol 93:105396. https://doi.org/10.1016/j.jddst.2024.10539610.1016/j.jddst.2024.105396 ↗

23. Gong L, Zhang Y, Liu C, Zhang M, Han S (2021) Application of radiosensitizers in cancer radiotherapy. Int J Nanomedicine 16:1083–1102. https://doi.org/10.2147/IJN.S29043810.2147/IJN.S290438 ↗

24. Komorowska D, Radzik T, Kalenik S, Rodacka A (2022) Natural radiosensitizers in radiotherapy: cancer treatment by combining ionizing radiation with resveratrol. Int J Mol Sci 23:10627. https://doi.org/10.3390/ijms23181062710.3390/ijms231810627 ↗

25. Zhao Y, Tan F, Zhao J, Zhou S, Luo Y, Gong C (2025) Targeting the enhanced sensitivity of radiotherapy in cancer: mechanisms, applications, and challenges. MedComm (2020) 6:e70202. https://doi.org/10.1002/mco2.7020210.1002/mco2.70202 ↗

26. Jiang X, Jiang X, Wu D, Xie W, Liu X, Zheng J (2024) A pH-sensitive nanoparticle as reactive oxygen species amplifier to regulate tumor microenvironment and potentiate tumor radiotherapy. Int J Nanomedicine 19:709–725. https://doi.org/10.2147/IJN.S43616010.2147/IJN.S436160 ↗

27. Luan S, Xie R, Yang Y, Xiao X, Zhou J, Li X, Fang P, Zeng X, Yu X, Chen M, Gao H, Yuan Y (2022) Acid-responsive aggregated gold nanoparticles for radiosensitization and synergistic chemoradiotherapy in the treatment of esophageal cancer. Small 18:e2200115. https://doi.org/10.1002/smll.20220011510.1002/smll.202200115 ↗

28. Liu W, Deacon J, Yan H, Sun B, Liu Y, Hegan D, Li Q, Coman D, Parent M, Hyder F, Roberts K, Nath R, Tillement O, Engelman D, Glazer P (2020) Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy. Transl Oncol 13:100839. https://doi.org/10.1016/j.tranon.2020.10083910.1016/j.tranon.2020.100839 ↗

29. Zhang Y, Huang F, Ren C, Liu J, Yang L, Chen S, Chang J, Yang C, Wang W, Zhang C, Liu Q, Liang XJ, Liu J (2019) Enhanced radiosensitization by gold nanoparticles with acid-triggered aggregation in cancer radiotherapy. Adv Sci Weinh 6:1801806. https://doi.org/10.1002/advs.20180180610.1002/advs.201801806 ↗

30. Liu K, Zheng D, Zhao J, Tao Y, Wang Y, He J, Lei J, Xi X (2018) pH-sensitive nanogels based on the electrostatic self-assembly of radionuclide (131)I labeled albumin and carboxymethyl cellulose for synergistic combined chemo-radioisotope therapy of cancer. J Mater Chem B 6:4738–4746. https://doi.org/10.1039/c8tb01295d10.1039/c8tb01295d ↗

31. Chen Y, Yang C, Mao J, Li H, Ding J, Zhou W (2019) Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy. RSC Adv 9:11026–11037. https://doi.org/10.1039/c9ra00834a10.1039/c9ra00834a ↗

32. Shen H, Huang H, Jiang Z (2023) Nanoparticle-based radiosensitization strategies for improving radiation therapy. Front Pharmacol 14:1145551. https://doi.org/10.3389/fphar.2023.114555110.3389/fphar.2023.1145551 ↗

33. Xie G, Wang F, Ma X (2025) Strategies and mechanisms of radiosensitization in cancer therapy. Biophys Rep. https://doi.org/10.52601/bpr.2025.25005610.52601/bpr.2025.250056 ↗

34. An L, Li M, Jia Q (2023) Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer 22:140. https://doi.org/10.1186/s12943-023-01839-210.1186/s12943-023-01839-2 ↗

35. Kabakov AE, Yakimova AO (2021) Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers 13:1102. https://doi.org/10.3390/cancers1305110210.3390/cancers13051102 ↗

36. Howard D, Sebastian S, Le QV, Thierry B, Kempson I (2020) Chemical mechanisms of nanoparticle radiosensitization and radioprotection: a review of structure-function relationships influencing reactive oxygen species. Int J Mol Sci 21:579. https://doi.org/10.3390/ijms2102057910.3390/ijms21020579 ↗

37. Liu J, Wu J, Chen T, Yang B, Liu X, Xi J, Zhang Z, Gao Y, Li Z (2024) Enhancing X-ray sensitization with multifunctional nanoparticles. Small 20:e2400954. https://doi.org/10.1002/smll.20240095410.1002/smll.202400954 ↗

38. Chen Y, Yang J, Fu S, Wu J (2020) Gold nanoparticles as radiosensitizers in cancer radiotherapy. Int J Nanomedicine 15:9407–9430. https://doi.org/10.2147/IJN.S27290210.2147/IJN.S272902 ↗

39. Pan Y, Tang W, Fan W, Zhang J, Chen X (2022) Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection. Chem Soc Rev 51:9759–9830. https://doi.org/10.1039/d1cs01145f10.1039/d1cs01145f ↗

40. Arif M, Nawaz AF, Ullah Khan S, Mueen H, Rashid F, Hemeg HA, Rauf A (2023) Nanotechnology-based radiation therapy to cure cancer and the challenges in its clinical applications. Heliyon 9:e17252. https://doi.org/10.1016/j.heliyon.2023.e1725210.1016/j.heliyon.2023.e17252 ↗

41. Gavas S, Quazi S, Karpinski TM (2021) Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett 16:173. https://doi.org/10.1186/s11671-021-03628-610.1186/s11671-021-03628-6 ↗

42. Sih BT, Ahmed AT, Jawad M, Al-Hetty HRAK, Rekha M, Soothwal P, Naidu KS, Arya R, Mustafa YF, Abosaoda MK (2025) Nanoparticle-based radiosensitization strategies in nuclear medicine: current status and future directions. J Radioanal Nucl Chem. https://doi.org/10.1007/s10967-025-10010-810.1007/s10967-025-10010-8 ↗

43. Liu J, Wang H, Yi X, Chao Y, Geng Y, Xu L, Yang K, Liu Z (2017) pH‐sensitive dissociable nanoscale coordination polymers with drug loading for synergistically enhanced chemoradiotherapy. Adv Funct Mater 27:170383210.1002/adfm.201703832 ↗

44. Boedtkjer E, Pedersen SF (2020) The acidic tumor microenvironment as a driver of cancer. Annu Rev Physiol 82:103–126. https://doi.org/10.1146/annurev-physiol-021119-03462710.1146/annurev-physiol-021119-034627 ↗

45. Jiang Y, Wu Q, Hou M, Hai W, Zhang M, Li B, Zhang C (2023) pH-sensitive gold nanoclusters labeling with radiometallic nuclides for diagnosis and treatment of tumor. Mater Today Bio 19:100578. https://doi.org/10.1016/j.mtbio.2023.10057810.1016/j.mtbio.2023.100578 ↗

46. Yu L, Zhang X, Li X, Zhang Z, Niu X, Wang X, Wang W, Yuan Z (2021) A pH-responsive Pt-based nanoradiosensitizer for enhanced radiotherapy via oxidative stress amplification. Nanoscale 13:13735–13745. https://doi.org/10.1039/d1nr02043a10.1039/d1nr02043a ↗

47. Lim SH, Li CH, Jeong YI, Jang WY, Choi JM, Jung S (2019) Enhancing radiotherapeutic effect with nanoparticle-mediated radiosensitizer delivery guided by focused gamma rays in lewis lung carcinoma-bearing mouse brain tumor models. Int J Nanomedicine 14:8861–8874. https://doi.org/10.2147/IJN.S22789410.2147/IJN.S227894 ↗

48. Zhang X, Zhang C, Cheng M, Zhang Y, Wang W, Yuan Z (2019) Dual pH-responsive “charge-reversal like” gold nanoparticles to enhance tumor retention for chemo-radiotherapy. Nano Res 12:2815–2826. https://doi.org/10.1007/s12274-019-2518-110.1007/s12274-019-2518-1 ↗

49. Jung J, Kim MS, Park S-J, Chung HK, Choi J, Park J, Jin D-H, Song SY, Park HJ, Lee DS (2012) Enhancement of radiotherapeutic efficacy by paclitaxel‐loaded pH‐sensitive block copolymer micelles. J Nanomater 2012:867036. https://doi.org/10.1155/2012/86703610.1155/2012/867036 ↗

50. Shirvalilou S, Khoei S, Khoee S, Mahdavi SR, Raoufi NJ, Motevalian M, Karimi MY (2020) Enhancement radiation-induced apoptosis in C6 glioma tumor-bearing rats via pH-responsive magnetic graphene oxide nanocarrier. J Photochem Photobiol B 205:111827. https://doi.org/10.1016/j.jphotobiol.2020.11182710.1016/j.jphotobiol.2020.111827 ↗

51. Durand M, Chateau A, Jubreaux J, Devy J, Paquot H, Laurent G, Bazzi R, Roux S, Richet N, Reinhard-Ruch A, Chastagner P, Pinel S (2023) Radiosensitization with gadolinium chelate-coated gold nanoparticles prevents aggressiveness and invasiveness in glioblastoma. Int J Nanomedicine 18:243–261. https://doi.org/10.2147/IJN.S37591810.2147/IJN.S375918 ↗

52. Dubey P, Sertorio M, Takiar V (2022) Therapeutic advancements in metal and metal oxide nanoparticle-based radiosensitization for head and neck cancer therapy. Cancers (Basel) 14:514. https://doi.org/10.3390/cancers1403051410.3390/cancers14030514 ↗

53. Guo Z, Sui J, Ma M, Hu J, Sun Y, Yang L, Fan Y, Zhang X (2020) pH-responsive charge switchable PEGylated epsilon-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment. J Control Release 326:350–364. https://doi.org/10.1016/j.jconrel.2020.07.03010.1016/j.jconrel.2020.07.030 ↗

54. Ismail M, Wang Y, Li Y, Liu J, Zheng M, Zou Y (2024) Stimuli-responsive polymeric nanocarriers accelerate on-demand drug release to combat glioblastoma. Biomacromolecules 25:6250–6282. https://doi.org/10.1021/acs.biomac.4c0072210.1021/acs.biomac.4c00722 ↗

55. Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, Such GK (2024) Polymeric nanoparticles for drug delivery. Chem Rev 124:5505–5616. https://doi.org/10.1021/acs.chemrev.3c0070510.1021/acs.chemrev.3c00705 ↗

56. Wang Y, Zhang M, Yan Z, Ji S, Xiao S, Gao J (2024) Metal nanoparticle hybrid hydrogels: the state-of-the-art of combining hard and soft materials to promote wound healing. Theranostics 14:1534–1560. https://doi.org/10.7150/thno.9182910.7150/thno.91829 ↗

57. Jia L, Zhang P, Sun H, Dai Y, Liang S, Bai X, Feng L (2021) Optimization of nanoparticles for smart drug delivery: a review. Nanomaterials (Basel) 11:2790. https://doi.org/10.3390/nano1111279010.3390/nano11112790 ↗

58. Li M, Zhou S, Zhang Y, Li J, Zhang K (2025) Advancements in tumor-targeted nanoparticles: design strategies and multifunctional therapeutic approaches. Nanomaterials (Basel) 15:1262. https://doi.org/10.3390/nano1516126210.3390/nano15161262 ↗

59. Boulding K (2023) Microfluidic synthesis of silver-loaded, pH-sensitive nanogels for enhanced radiotherapy. MSc Thesis, University of Victoria, Canada

60. Chu S, Shi X, Tian Y, Gao F (2022) pH-responsive polymer nanomaterials for tumor therapy. Front Oncol 12:855019. https://doi.org/10.3389/fonc.2022.85501910.3389/fonc.2022.855019 ↗

61. Das A, Chadha R, Maiti N, Kapoor S (2015) Synthesis of pH sensitive gold nanoparticles for potential application in radiosensitization. Mater Sci Eng C Mater Biol Appl 55:34–41. https://doi.org/10.1016/j.msec.2015.05.04810.1016/j.msec.2015.05.048 ↗

62. Pandey V, Pandey T (2025) Mechanistic understanding of pH as a driving force in cancer therapeutics. J Mater Chem B 13:2640–2657. https://doi.org/10.1039/d4tb02083a10.1039/d4tb02083a ↗

63. Peukert D, Kempson I, Douglass M, Bezak E (2018) Metallic nanoparticle radiosensitisation of ion radiotherapy: a review. Phys Med 47:121–128. https://doi.org/10.1016/j.ejmp.2018.03.00410.1016/j.ejmp.2018.03.004 ↗

64. Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, Chithrani BD, Cho SH, Cook JR, Favaudon V, Gholami YH, Gargioni E, Hainfeld JF, Hespeels F, Heuskin AC, Ibeh UM, Kuncic Z, Kunjachan S, Lacombe S, Lucas S, Lux F, McMahon S, Nevozhay D, Ngwa W, Payne JD, Penninckx S, Porcel E, Prise KM, Rabus H, Ridwan SM, Rudek B, Sanche L, Singh B, Smilowitz HM, Sokolov KV, Sridhar S, Stanishevskiy Y, Sung W, Tillement O, Virani N, Yantasee W, Krishnan S (2020) Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Phys Med Biol 65:21RM02. https://doi.org/10.1088/1361-6560/ab915910.1088/1361-6560/ab9159 ↗

65. Nie Y, Li D, Peng Y, Wang S, Hu S, Liu M, Ding J, Zhou W (2020) Metal organic framework coated MnO(2) nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer. Int J Pharm 585:119513. https://doi.org/10.1016/j.ijpharm.2020.11951310.1016/j.ijpharm.2020.119513 ↗

66. Dong L, Ding J, Zhu L, Liu Y, Gao X, Zhou W (2023) Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy. Chin Chem Lett 34:108192. https://doi.org/10.1016/j.cclet.2023.10819210.1016/j.cclet.2023.108192 ↗

67. Ruan B, Zheng Z, Kayitmazer AB, Ahmad A, Ramzan N, Rafique MS, Wang J, Xu Y (2024) Polymeric pH-responsive metal-supramolecular nanoparticles for synergistic chemo-photothermal therapy. Langmuir 40:16813–16823. https://doi.org/10.1021/acs.langmuir.4c0120810.1021/acs.langmuir.4c01208 ↗

68. Wason MS, Colon J, Das S, Seal S, Turkson J, Zhao J, Baker CH (2013) Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine 9:558–569. https://doi.org/10.1016/j.nano.2012.10.01010.1016/j.nano.2012.10.010 ↗

69. Mai BT, Fernandes S, Balakrishnan PB, Pellegrino T (2018) Nanosystems based on magnetic nanoparticles and thermo- or pH-responsive polymers: an update and future perspectives. Acc Chem Res 51:999–1013. https://doi.org/10.1021/acs.accounts.7b0054910.1021/acs.accounts.7b00549 ↗

70. Feng Q, Wilhelm J, Gao J (2019) Transistor-like ultra-pH-sensitive polymeric nanoparticles. Acc Chem Res 52:1485–1495. https://doi.org/10.1021/acs.accounts.9b0008010.1021/acs.accounts.9b00080 ↗

71. Verkhovskii RA, Ivanov AN, Lengert EV, Tulyakova KA, Shilyagina NY, Ermakov AV (2023) Current principles, challenges, and new metrics in pH-responsive drug delivery systems for systemic cancer therapy. Pharmaceutics 15:1566. https://doi.org/10.3390/pharmaceutics1505156610.3390/pharmaceutics15051566 ↗

72. Peng X, Han Q, Zhou X, Chen Y, Huang X, Guo X, Peng R, Wang H, Peng X, Cheng L (2022) Effect of pH-sensitive nanoparticles on inhibiting oral biofilms. Drug Deliv 29:561–573. https://doi.org/10.1080/10717544.2022.203778810.1080/10717544.2022.2037788 ↗

73. Hua L, Wang Z, Zhao L, Mao H, Wang G, Zhang K, Liu X, Wu D, Zheng Y, Lu J, Yu R, Liu H (2018) Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy. Theranostics 8:5088–5105. https://doi.org/10.7150/thno.2622510.7150/thno.26225 ↗

74. Li Z, Huang J, Wu J (2021) pH-sensitive nanogels for drug delivery in cancer therapy. Biomater Sci 9:574–589. https://doi.org/10.1039/d0bm01729a10.1039/d0bm01729a ↗

75. Jha A, Rama A, Ladani B, Verma N, Kannan S, Naha A (2021) Temperature and pH-responsive nanogels as intelligent drug delivery systems: a comprehensive review. J Appl Pharm Sci 11:001–016. https://doi.org/10.7324/JAPS.2021.110120110.7324/JAPS.2021.1101201 ↗

76. Cao Z, Li W, Liu R, Li C, Song Y, Liu G, Chen Y, Lu C, Lu A, Liu Y (2020) pH-responsive fluorescence enhanced nanogel for targeted delivery of AUR and CDDP against breast cancer. Int J Nanomedicine 15:8369–8382. https://doi.org/10.2147/IJN.S27484210.2147/IJN.S274842 ↗

77. Niaz S, Au S (2023) pH-responsive nanogels for site-specific drug delivery: synthesis, characterization, and stimuli-triggered release behavior. Biosens Nanotheranostics 2:1–10. https://doi.org/10.25163/biosensors.21991610.25163/biosensors.219916 ↗

78. Dutta G, Manickam S, Sugumaran A (2022) Stimuli-responsive hybrid metal nanocomposite - a promising technology for effective anticancer therapy. Int J Pharm 624:121966. https://doi.org/10.1016/j.ijpharm.2022.12196610.1016/j.ijpharm.2022.121966 ↗

79. Askar MA, Thabet NM, El-Sayyad GS, El-Batal AI, Abd Elkodous M, El Shawi OE, Helal H, Abdel-Rafei MK (2021) Dual hyaluronic acid and folic acid targeting pH-sensitive multifunctional 2DG@DCA@MgO-nano-core-shell-radiosensitizer for breast cancer therapy. Cancers (Basel) 13:5571. https://doi.org/10.3390/cancers1321557110.3390/cancers13215571 ↗

80. Anirudhan T, Christa J (2020) Temperature and pH sensitive multi-functional magnetic nanocomposite for the controlled delivery of 5-fluorouracil, an anticancer drug. J Drug Deliv Sci Technol 55:10147610.1016/j.jddst.2019.101476 ↗

81. Andoh V, Ocansey DKW, Naveed H, Wang N, Chen L, Chen K, Mao F (2024) The advancing role of nanocomposites in cancer diagnosis and treatment. Int J Nanomedicine 19:6099–6126. https://doi.org/10.2147/IJN.S47136010.2147/IJN.S471360 ↗

82. Bertrand P, Blanquart C, Heroguez V (2019) The ROMP: a powerful approach to synthesize novel pH-sensitive nanoparticles for tumor therapy. Biomolecules 9:60. https://doi.org/10.3390/biom902006010.3390/biom9020060 ↗

83. Sun H, Li X, Liu Q, Sheng H, Zhu L (2024) pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery. J Drug Target 32:672–706. https://doi.org/10.1080/1061186X.2024.234912410.1080/1061186X.2024.2349124 ↗

84. Liu C, Liu Q, Chen L, Li M, Yin J, Zhu X, Chen D (2020) A pH-sensitive self-assembled and carrier-free nanoparticle based on charge reversal for enhanced synergetic chemo-phototherapy. Adv Healthc Mater 9:e2000899. https://doi.org/10.1002/adhm.20200089910.1002/adhm.202000899 ↗

85. Yan G, Chen R, Xiong N, Song J, Wang X, Tang R (2020) pH-sensitive small molecule nanodrug self-assembled from amphiphilic vitamin B6-E analogue conjugate for targeted synergistic cancer therapy. Colloids Surf B Biointerfaces 191:111000. https://doi.org/10.1016/j.colsurfb.2020.11100010.1016/j.colsurfb.2020.111000 ↗

86. Sun X, Yu K, Zhou Y, Dong S, Hu W, Sun Y, Li Y, Xie J, Lee RJ, Sun F, Ma Y, Wang S, Kim BYS, Wang Y, Yang Z, Jiang W, Li Y, Teng L (2021) Self-assembled pH-sensitive polymeric nanoparticles for the inflammation-targeted delivery of Cu/Zn-superoxide dismutase. ACS Appl Mater Interfaces 13:18152–18164. https://doi.org/10.1021/acsami.1c0358910.1021/acsami.1c03589 ↗

87. Saravanakumar G, Kim J, Kim WJ (2017) Reactive-oxygen-species-responsive drug delivery systems: promises and challenges. Adv Sci (Weinh) 4:1600124. https://doi.org/10.1002/advs.20160012410.1002/advs.201600124 ↗

88. Zhang B, Wan S, Peng X, Zhao M, Li S, Pu Y, He B (2020) Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity. J Mater Chem B 8:3939–3948. https://doi.org/10.1039/d0tb00327a10.1039/d0tb00327a ↗

89. Hompland T, Fjeldbo CS, Lyng H (2021) Tumor hypoxia as a barrier in cancer therapy: why levels matter. Cancers (Basel) 13:499. https://doi.org/10.3390/cancers1303049910.3390/cancers13030499 ↗

90. Hill RM, Rocha S, Parsons JL (2022) Overcoming the impact of hypoxia in driving radiotherapy resistance in head and neck squamous cell carcinoma. Cancers (Basel) 14:4130. https://doi.org/10.3390/cancers1417413010.3390/cancers14174130 ↗

91. Zhang S, Chen W, Zhou J, Liang Q, Zhang Y, Su M, Zhang Z, Qu J (2025) The benefits and safety of monoclonal antibodies: implications for cancer immunotherapy. J Inflamm Res 18:4335–4357. https://doi.org/10.2147/JIR.S49940310.2147/JIR.S499403 ↗

92. Zhang R, Wang T, Shen H, Zhou X, Han Q, Li L, Zhang L, Wang C, Dong X (2025) Tumor microenvironment-responsive MnOx-mesoporous carbon nanoparticles for enhanced chemodynamic synergistic antitumor therapy. ACS Appl Nano Mater 8:2763–2773. https://doi.org/10.1021/acsanm.4c0625710.1021/acsanm.4c06257 ↗

93. Li X, Yue R, Guan G, Zhang C, Zhou Y, Song G (2023) Recent development of pH‐responsive theranostic nanoplatforms for magnetic resonance imaging‐guided cancer therapy. Exploration. https://doi.org/10.1002/EXP.2022000210.1002/EXP.20220002 ↗

94. Wang X, Sun K, Dong J, Ge Y, Liu H, Jin X, Pei X, Wang P, Jiang J, Wang T, Hu X, Yuan S, Wang B, Yu XA (2025) Carrier-free nanoparticles based on natural products trigger dual “synergy and attenuation” for enhanced phototherapy of liver cancer. Mater Today Bio 35:102278. https://doi.org/10.1016/j.mtbio.2025.10227810.1016/j.mtbio.2025.102278 ↗

95. Liang Q, Zeng J, Jiang Z, Zhang W, Yang X, Tian J, Zhao Z, Du Y (2025) Multivoid magnetic nanoparticles as high-performance magnetic particle imaging tracers for precise glioma detection. Bioconjug Chem. https://doi.org/10.1021/acs.bioconjchem.5c0052710.1021/acs.bioconjchem.5c00527 ↗

96. Zhou Y, Sun X, Zhou L, Zhang X (2020) pH-sensitive and long-circulation nanoparticles for near-infrared fluorescence imaging-monitored and chemo-photothermal synergistic treatment against gastric cancer. Front Pharmacol 11:610883. https://doi.org/10.3389/fphar.2020.61088310.3389/fphar.2020.610883 ↗

97. Jiang D, Zhu L, Tong S, Shen Y, Gao F, Gao F (2024) Photoacoustic imaging plus X: a review. J Biomed Opt 29:S11513. https://doi.org/10.1117/1.JBO.29.S1.S1151310.1117/1.JBO.29.S1.S11513 ↗

98. Wang L, Zeng W, Long K, Chen H, Lan R, Liu L, Siok WT, Wang N (2024) Advances in photoacoustic imaging reconstruction and quantitative analysis for biomedical applications, arXiv preprint arXiv:2411.02843. https://doi.org/10.48550/arXiv.2411.0284310.48550/arXiv.2411.02843 ↗

99. Park J, Choi S, Knieling F, Clingman B, Bohndiek S, Wang LV, Kim C (2024) Clinical translation of photoacoustic imaging. Nat Rev Bioeng. https://doi.org/10.1038/s44222-024-00240-y10.1038/s44222-024-00240-y ↗

100. Du J, Yang S, Qiao Y, Lu H, Dong H (2021) Recent progress in near-infrared photoacoustic imaging. Biosens Bioelectron 191:113478. https://doi.org/10.1016/j.bios.2021.11347810.1016/j.bios.2021.113478 ↗